These observations support previous in vitro and in vivo findings, suggesting that unlike the wild-type AR, the continuously active mutations Q62L and E81Q in AR are independent driver oncogene mutations in hepatocarcinogenesis and showed high malignancy similar to strong cancer-promoting genes such as AKT and C-MYC. The gene discussed is MYC; the disease is cancer.